Does the NIH policy encourage or discourage any particular data formats for clinical trials? For example SAS?
Answer
They will likely encourage data formats and coding languages/systems that are open source. However, they do not forbid analytics that require a subscription (e.g. MATLAB, SAS, MATHEMATICA, etc.). The data itself, however, should be in an accessable format that is standard in the field (e.g. CSV, DICOM, FCS3, etc.)